Fred Dick, PhD

Fred Dick

 

Scientist: London Regional Cancer Program, London Health Sciences Centre, London, Ontario
Assistant Professor: Department of Biochemistry, University of Western Ontario, London, Ontario
Cross Appointment: Department of Oncology

 

University Website

http://www.biochem.uwo.ca/fac/dick/Lab%20Web%20Page/Home.html

 

Mailing Address

London Regional Cancer Program
Room A4-136, Cancer Research Laboratory Program
790 Commissioners Rd. E.
London, Ontario
Canada N6A 4L6

Tel: 519.685.8620
Fax: 519.685.8616
Email: fdick@uwo.ca

Staff and Trainees

Graduate Students:

Mehdi Amiri

Matt Cecchini

Courtney Coschi

Charles Ishak

Paul Stafford

Srikanth Talluri

Mike Thwaites

                                 
Research Technician:

Daniel Passos      

Research Associate:       

James MacDonald                                    

Research Area


Cell cycle regulation in development and oncogenesis

Key Words

Laboratory

Laboratory research is focused on the fundamental mechanisms that regulate the mammalian cell cycle and how they are disrupted in cancer. This is carried out by using cell culture, in vitro biochemical, and mouse gene-targeting technologies.

Summary of Current Work

Regulation of Cell Proliferation in Cancer Regulation of the mammalian cell division cycle is critical to development as cell cycle exit and differentiation are intimately linked with patterning and tissue morphogenesis.  Loss of proliferative control during development is catastrophic, as it leads to apoptosis and tissue degeneration.  Loss of cell cycle control is also important in disease pathology, as deregulated proliferation is a defining feature of cancer.
    

The G1 phase of the cell cycle is the stage at which a cell can decide to replicate its DNA and divide, or exit the cell cycle.  As such, understanding the molecular mechanisms that control this decision making process is central to understanding development and cancer.  The master regulator of progression through the G1 phase of the cell cycle is the Retinoblastoma protein (pRB).  Its function is disabled in nearly all forms of human cancer.  
  

Despite the central role of pRB in cell cycle control, it is unclear how it interprets regulatory signals in G1 and controls cyclin dependent kinases and transcription.  This deficiency stems from the fact that pRB uses a single growth suppressive domain called the ‘pocket’ to mediate most of its regulatory functions.  Dissection of function within this domain has been challenging because cancer derived mutations destroy all interactions with this domain causing a myriad of functional consequences.  In sum, without a concise mechanistic understanding of the retinoblastoma protein’s function, much of the regulation of cell proliferation in development and disease will remain a mystery. 

PubMed Publications


See my publications on PubMed

LHSCResearch & Training

Virtual Orientation
Virtual Orientations
For New PatientsFor New Patients Glossary of TermsGlossary of Terms Quick LinksQuick Links Contact LRCPContact LRCP Parking, Maps, DirectionsParking, Maps, Directions Upcoming EventsUpcoming Events Canadian Cancer Society Cancer Care Ontario A Cancer Care Ontario Partner
Last Updated October 10, 2012 | © 2007, LHSC, London Ontario Canada